Cargando…

Type 2 cytokines and scleroderma interstitial lung disease

Interstitial lung disease (ILD) is a life-threatening complication of systemic sclerosis (SSc). Type 2 (Th2) cytokines play a pivotal role in airway disease. Study aim was to evaluate serum level of Th2 interleukin (IL) and chemokine in SSc-ILD. Serum levels of IL-4, IL-5, IL-11, IL-13, IL-21, IL-31...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellicano, Chiara, Vantaggio, Lorenzo, Colalillo, Amalia, Pocino, Krizia, Basile, Valerio, Marino, Mariapaola, Basile, Umberto, Rosato, Edoardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618297/ https://www.ncbi.nlm.nih.gov/pubmed/37392249 http://dx.doi.org/10.1007/s10238-023-01125-x

Ejemplares similares

Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis
por: Pellicano, Chiara, et al.
Publicado: (2022)

In Systemic Sclerosis Patients, Peripheral Blood CD21(low) B Cells and Serum IL-4 and IL-21 Influence Joint Involvement
por: Pellicano, Chiara, et al.
Publicado: (2023)

The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients
por: Pellicano, Chiara, et al.
Publicado: (2022)

Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis
por: Leodori, Giorgia, et al.
Publicado: (2022)

Interleukin-33 and soluble suppression of tumorigenicity 2 in scleroderma cardiac involvement
por: Iannazzo, Francesco, et al.
Publicado: (2022)

Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace
por: Pocino, Krizia, et al.
Publicado: (2022)

Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis
por: Basile, Umberto, et al.
Publicado: (2021)

Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients
por: Pellicano, Chiara, et al.
Publicado: (2023)

In systemic sclerosis TAPSE/sPAP ratio is correlated with ventilatory efficiency and exercise capacity assessed by CPET
por: Colalillo, Amalia, et al.
Publicado: (2022)

Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients
por: Basile, Umberto, et al.
Publicado: (2018)

Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis
por: Pellicano, Chiara, et al.
Publicado: (2021)

A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma
por: Pocino, Krizia, et al.
Publicado: (2021)

Evaluation of Free Light Chains of Immunoglobulins in Seminal Plasma of Infertile Patients: Preliminary Data
por: Bruno, Carmine, et al.
Publicado: (2021)

Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate
por: Napodano, Cecilia, et al.
Publicado: (2023)

Scleroderma-related interstitial lung disease
por: Suliman, Sally, et al.
Publicado: (2017)

Targeting the NLRP3 inflammasome and associated cytokines in scleroderma associated interstitial lung disease
por: Woo, Samuel, et al.
Publicado: (2023)

Cryoglobulin Test and Cryoglobulinemia Hepatitis C-Virus Related
por: Gulli, Francesca, et al.
Publicado: (2017)

Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis
por: Pellicano, Chiara, et al.
Publicado: (2022)

Interstitial lung disease in patients with scleroderma - Treatment with rituximab
por: Muñoz, A, et al.
Publicado: (2010)

Scleroderma and interstitial lung disease - A case report
por: Gul, Fahad, et al.
Publicado: (2022)

Might IgA be a Biomarker of Disease Activity in Takayasu Arteritis?
por: Vantaggio, Lorenzo, et al.
Publicado: (2022)

MON-448 Inflammatory and Oxidative Stress Parameters as Criteria of Classification of Metabolic Phenotypes of Insulin Resistance
por: Bruno, Carmine, et al.
Publicado: (2019)

Elevated serum polyclonal immunoglobulin free light chains in patients with severe asthma
por: Basile, Umberto, et al.
Publicado: (2023)

Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins
por: Napodano, Cecilia, et al.
Publicado: (2021)

Defining genetic risk factors for scleroderma-associated interstitial lung disease: IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease
por: Stock, Carmel J. W., et al.
Publicado: (2020)

Safety and Tolerability of Thrombin Inhibition in Scleroderma‐Associated Interstitial Lung Disease
por: Silver, R. M., et al.
Publicado: (2019)

Emphysematous change with scleroderma-associated interstitial lung disease: the potential contribution of vasculopathy?
por: Yamakawa, Hideaki, et al.
Publicado: (2018)

Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
por: Napodano, Cecilia, et al.
Publicado: (2023)

Mycophenolate mofetil for scleroderma-related interstitial lung disease: A real world experience
por: Baqir, Misbah, et al.
Publicado: (2017)

Long Term Effects of Cyclophosphamide Treatment on Lung Function and Survival in Scleroderma Patients with Interstitial Lung Disease
por: Mittoo, S, et al.
Publicado: (2011)

β-thymosins and interstitial lung disease: study of a scleroderma cohort with a one-year follow-up
por: De Santis, Maria, et al.
Publicado: (2011)

Variation of usual interstitial pneumonia using HRCT in Scleroderma Patients
por: Wulani, Vally, et al.
Publicado: (2021)

Anti-Ro52 Antibodies and Interstitial Lung Disease in Connective Tissue Diseases Excluding Scleroderma
por: Ferreira, João Pedro, et al.
Publicado: (2012)

Multidisciplinary Approach to Interstitial Lung Diseases: Nothing Is Better than All of Us Together
por: Vancheri, Carlo, et al.
Publicado: (2020)

In systemic sclerosis patients the anxiety disorder and Raynaud’s phenomenon are increased during lock down period for COVID-19 pandemic
por: Gigante, Antonietta, et al.
Publicado: (2020)

Scleroderma specific autoantibodies in rheumatoid arthritis and Sjögren's syndrome patients with interstitial lung disease: Prevalence and associations
por: Koulouri, Vasiliki, et al.
Publicado: (2022)

Emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia
por: Yamakawa, Hideaki, et al.
Publicado: (2018)

Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-related Interstitial Lung Disease: Scleroderma Lung Study II (SLS-II), a double-blind, parallel group, randomised controlled trial
por: Tashkin, Donald P, et al.
Publicado: (2016)

Scleroderma with Nodular Scleroderma
por: Srisuttiyakorn, Chutika, et al.
Publicado: (2016)

Systemic scleroderma-related interstitial pneumonia associated with borderline pulmonary arterial hypertension
por: Sugino, Keishi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fq8d96bq9bmgk79ehv1fsk0e8k